Therefore, a better understanding of the substrate supply to nNOS is necessary to find new possibilities to treat illnesses where an increased level of NO produced by nNOS causes damage in the brain (as Alzheimer’s or Parkinson’s disease, multiple sclerosis and stroke) [13], [17], [18]. The gene discussed is NOS1; the disease is multiple sclerosis.